FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Al

Search Health Board

Pharmacy: Drugs and Medications: O: Omalizumab: FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Al	Next

FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Al June 2003 article on the drug's US approval. Includes information about results of clinical trials. http://www.aaaai.org/members/hottopic/omalizumab/professional.stm.	Free Classified Ads